Cholesterol esters as growth regulators of lymphocytic leukaemia cells
暂无分享,去创建一个
A. Pani | A. Mandas | C. Abete | B. Massidda | M. F. Mulas | S. Dessì | D. Pulisci | Claudia Abete
[1] A. Uittenbogaard,et al. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae. , 2013, The Journal of Biological Chemistry.
[2] R. Stam,et al. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. , 2010, Blood.
[3] R. Gniadecki,et al. Cholesterol and Lipid Rafts as Regulators of Signaling Through the EGFReceptor in Keratinocytes , 2009 .
[4] K. Stuhlmeier,et al. Liver X Receptors Interfere with Cytokine- Induced Proliferation and Cell Survival in Normal and Leukemic Lymphocytes , 2009 .
[5] C. Enrich,et al. Annexins--modulators of EGF receptor signalling and trafficking. , 2009, Cellular signalling.
[6] L. Pike,et al. Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding. , 2009, Biochemistry.
[7] R. Landgraf,et al. Signaling through ERBB receptors: multiple layers of diversity and control. , 2006, Cellular signalling.
[8] S. Ye,et al. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. , 2006, The American journal of pathology.
[9] J. Breslow,et al. Intracellular Cholesterol Transport , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[10] Rhoderick E. Brown,et al. Cholesterol Depletion Results in Site-specific Increases in Epidermal Growth Factor Receptor Phosphorylation due to Membrane Level Effects , 2003, Journal of Biological Chemistry.
[11] D. Wallwiener,et al. Statins can inhibit proliferation of human breast cancer cells in vitro. , 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[12] M. Resh,et al. Cholesterol Depletion from the Plasma Membrane Triggers Ligand-independent Activation of the Epidermal Growth Factor Receptor* , 2002, The Journal of Biological Chemistry.
[13] I. Madshus,et al. Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae. , 2002, Journal of cell science.
[14] C. Fielding,et al. Cholesterol and caveolae: structural and functional relationships. , 2000, Biochimica et biophysica acta.
[15] J. Gmiński,et al. Serum HDL cholesterol concentration in patients with squamous cell and small cell lung cancer. , 2000, International journal of molecular medicine.
[16] D. Mangelsdorf,et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. , 2000, Science.
[17] P. Nowell,et al. The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Engelman,et al. p42/44 MAP Kinase-dependent and -independent Signaling Pathways Regulate Caveolin-1 Gene Expression , 1999, The Journal of Biological Chemistry.
[19] Richard G. W. Anderson,et al. Regulated Migration of Epidermal Growth Factor Receptor from Caveolae* , 1999, The Journal of Biological Chemistry.
[20] R. Parton,et al. Membrane microdomains and caveolae. , 1999, Current opinion in cell biology.
[21] M. Maa,et al. c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function* , 1999, The Journal of Biological Chemistry.
[22] M. Hallek,et al. Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival , 1999, Journal of Molecular Medicine.
[23] G. Gahrton,et al. Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation. , 1998, The American journal of pathology.
[24] Richard G. W. Anderson,et al. Cholesterol Depletion of Caveolae Causes Hyperactivation of Extracellular Signal-related Kinase (ERK)* , 1998, The Journal of Biological Chemistry.
[25] E. Ikonen,et al. Functional rafts in cell membranes , 1997, Nature.
[26] L. Tessitore,et al. Clinical remission is associated with restoration of normal high-density lipoprotein cholesterol levels in children with malignancies. , 1995, Clinical science.
[27] R. Sutherland,et al. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[28] L. Tessitore,et al. Cholesterol content in tumor tissues is inversely associated with high‐density lipoprotein cholesterol in serum in patients with gastrointestinal cancer , 1994, Cancer.
[29] P. Stacpoole,et al. In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma. , 1991, Journal of lipid research.
[30] R. Clayman,et al. Abnormal cholesterol metabolism in renal clear cell carcinoma. , 1987, Journal of lipid research.
[31] R. Pittman,et al. A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. , 1987, The Journal of biological chemistry.
[32] J. Oram,et al. Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization. , 1987, The Journal of biological chemistry.
[33] J. Albers,et al. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.
[34] M. Brown,et al. Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. , 1978, Blood.
[35] M. Shinitzky,et al. Cholesterol as a bioregulator in the development and inhibition of leukemia. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[36] W. R. Bloor,et al. LIPID CONTENT OF TUMORS. , 1932, The Journal of clinical investigation.
[37] C. Cellai,et al. Altered cholesterol ester cycle in skin fibroblasts from patients with Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[38] A. Pani,et al. CELL GROWTH AND CHOLESTEROL ESTERS , 2004 .
[39] M. Freeman,et al. Cholesterol and prostate cancer , 2004, Journal of cellular biochemistry.
[40] Kelvin K. W. Chan,et al. The statins as anticancer agents. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] G. Ness,et al. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[42] A. Fadda,et al. HDL subfractions as altered in cancer patients. , 1995, Journal of pharmaceutical and biomedical analysis.
[43] S. Umeki,et al. Decreases in serum cholesterol levels in advanced lung cancer. , 1993, Respiration; international review of thoracic diseases.
[44] L. Tessitore,et al. Altered pattern of lipid metabolism in patients with lung cancer. , 1992, Oncology.
[45] A. Kandutsch,et al. The role of cholesterol in malignancy. , 1978, Progress in experimental tumor research.
[46] A. Roffo. Heliotropism of Cholesterol in Relation to Skin Cancer , 1933 .